Mankind Pharma has received approval from board of directors to incorporate wholly owned subsidiary (WOS), directly or indirectly, in Russia (Foreign WOS). The Foreign WOS shall carry out the business of distribution of Pharmaceutical products of Bharat Serums and Vaccines, a material wholly owned subsidiary of the Company.
The company has also received approval for incorporation of a wholly owned subsidiary under Section 8 of the Companies Act, 2013 (Indian WOS) for undertaking CSR activities of the Mankind Group. The Board of Directors of the Company at its meeting held on April 14, 2025, has inter-alia, considered and approved the same.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
